Evidence map›Paper›PMID 42568971›Full record

ArticleThe British journal of cardiology2026

Risk of cardiovascular events in kidney transplant recipients undergoing PCI: a systematic review and meta-analysis.

Isabella Ellison, Riley Batchelor, Geoffrey Hill, David Chye, William Wilson, Ravi Iyer, Jeffrey Lefkovits, Nigel D Toussaint, Anoop N Koshy

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The British journal of cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Isabella EllisonMedical Doctor, Department of Cardiology and The University of Melbourne, The Royal Melbourne Hospital, Melbourne, Australia.
Riley BatchelorCardiologist, Department of Cardiology and The University of Melbourne, The Royal Melbourne Hospital, Melbourne, Australia; Department of Cardiology, The Alfred Hospital, Malborne, Australia; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
Geoffrey HillClinical & Research Support Librarian, The University of Melbourne, The Royal Melbourne Hospital, Melbourne, Australia.
David ChyeMedical Doctor, Department of Cardiology, Austin Health, Melbourne, Australia.
William WilsonInterventional Cardiologist, Department of Cardiology and The University of Melbourne, The Royal Melbourne Hospital, Melbourne, Australia.
Ravi IyerInterventional Cardiologist, Department of Cardiology and The University of Melbourne, The Royal Melbourne Hospital, Melbourne, Australia.
Jeffrey LefkovitsInterventional Cardiologist, Department of Cardiology and The University of Melbourne, The Royal Melbourne Hospital, Melbourne, Australia.
Nigel D ToussaintNephrologist, Department of Medicine, The University of Melbourne, Melbourne, Australia; Department of Nephrology, The Royal Melbourne Hospital, Melbourne, Australia.
Anoop N KoshyInterventional Cardiologist, Department of Cardiology and The University of Melbourne, The Royal Melbourne Hospital, Melbourne, Australia; Department of Medicine, The University of Melbourne, Melbourne, Australia; Department of Cardiology, Austin Health, Melbourne, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiovascular disease is a leading cause of mortality in patients with chronic kidney disease (CKD) and kidney transplant recipients (KTR). However, it remains uncertain whether KTR status predisposes patients to a heightened risk of major adverse cardiovascular events (MACE) following percutaneous coronary intervention (PCI). A systematic search was conducted using MEDLINE, EMBASE and Cochrane Central Register of Controlled Trials (CENTRAL), encompassing studies from inception to December 2024. The primary outcome was in-hospital mortality in KTR undergoing PCI compared with non-KTR cohorts. A random-effects model was used to analyse pooled data. A total of six studies with 13,287,090 patients were included. Four studies compared PCI outcomes in KTR with various degrees of renal dysfunction, revealing significantly lower in-hospital mortality in KTR compared with patients with CKD (odds ratio [OR] 0.44, 95% confidence interval [CI] 0.35 to 0.55, p<0.001). No significant difference was seen in in-hospital mortality between KTR and patients without CKD (OR 1.12, 95%CI 0.75 to 1.68, I

Indexed as

cardiovascular eventschronic kidney diseasedialysiskidney transplantpercutaneous coronary intervention (PCI)

Identifiers

PMID42568971
PMCPMC13448735

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.